失眠症认知行为治疗不同技术成分的效果比较研究

注册号:

Registration number:

ChiCTR2000037826 

最近更新日期:

Date of Last Refreshed on:

2020-11-08 13:11:32 

注册时间:

Date of Registration:

2020-09-02 00:00:00 

注册号状态:

预注册

Registration Status:

Prospective registration

注册题目:

失眠症认知行为治疗不同技术成分的效果比较研究

Public title:

A comparative study on the effects of cognitive behavioral therapy for insomnia with different components

注册题目简写:

English Acronym:

研究课题的正式科学名称:

失眠症认知行为治疗不同技术成分的效果比较研究

Scientific title:

A comparative study on the effects of cognitive behavioral therapy for insomnia with different components

研究课题代号(代码):

Study subject ID:

在二级注册机构或其它机构的注册号:

The registration number of the Partner Registry or other register:

申请注册联系人:

孟繁强 

研究负责人:

孟繁强 

Applicant:

Meng Fanqiang 

Study leader:

Meng Fanqiang 

申请注册联系人电话:

Applicant telephone:

+86 18311339611

研究负责人电话:

Study leader's
telephone:

+86 18311339611

申请注册联系人传真 :

Applicant Fax:

研究负责人传真:

Study leader's fax:

申请注册联系人电子邮件:

Applicant E-mail:

mfq_1019@126.com

研究负责人电子邮件:

Study leader's E-mail:

mfq_1019@126.com

申请单位网址(自愿提供):

Applicant website(voluntary supply):

研究负责人网址(自愿提供):

Study leader's website(voluntary supply):

申请注册联系人通讯地址:

北京市西城区德胜外大街安康胡同5号

研究负责人通讯地址:

北京市西城区德胜外大街安康胡同5号

Applicant address:

5 Ankang Hutong, Xicheng District, Beijing, China

Study leader's address:

5 Ankang Hutong, Xicheng District, Beijing, China

申请注册联系人邮政编码:

Applicant postcode:

研究负责人邮政编码:

Study leader's postcode:

申请人所在单位:

首都医科大学附属北京安定医院

Applicant's institution:

Beijing Anding Hospital Affiliated to Capital Medical University

研究负责人所在单位:

首都医科大学附属北京安定医院

Affiliation of the Leader:

Beijing Anding Hospital Affiliated to Capital Medical University

是否获伦理委员会批准:

Approved by ethic committee:

Yes

伦理委员会批件文号:

Approved No. of ethic committee:

2020科研第(69)号

伦理委员会批件附件:

Approved file of Ethical Committee:

查看附件View

批准本研究的伦理委员会名称:

首都医科大学附属北京安定医院伦理委员会

Name of the ethic committee:

Ethics Committee of Beijing Anding Hospital affiliated to Capital Medical University

伦理委员会批准日期:

Date of approved by ethic committee:

2020-08-25 00:00:00

伦理委员会联系人:

贾津晶

Contact Name of the ethic committee:

Jinjing Jia

伦理委员会联系地址:

首都医科大学附属北京安定医院3号楼2层伦理委员会办公室

Contact Address of the ethic committee:

Ethics Committee Office, 2nd Floor, Building 3, 5 Ankang Hutong, Xicheng District, Beijing, China

伦理委员会联系人电话:

Contact phone of the ethic committee:

伦理委员会联系人邮箱:

Contact email of the ethic committee:

研究实施负责(组长)单位:

首都医科大学附属北京安定医院

Primary sponsor:

Beijing Anding Hospital Affiliated to Capital Medical University

研究实施负责(组长)单位地址:

北京市⻄城区德胜⻔安康胡同5号

Primary sponsor's address:

5 Ankang Hutong, Xicheng District, Beijing, China

试验主办单位(项目批准或申办者):

Secondary sponsor:

国家:

中国

省(直辖市):

北京

市(区县):

Country:

China

Province:

Beijing

City:

单位(医院):

首都医科大学附属北京安定医院

具体地址:

西城区德胜外大街安康胡同5号

Institution
hospital:

Beijing Anding Hospital Affiliated to Capital Medical University

Address:

5 Ankang Hutong, Xicheng District

经费或物资来源:

北京市属医院科研培育项目

Source(s) of funding:

Beijing Municipal Administration of Hospitals Incubating Program

研究疾病:

失眠症  

Target disease:

insomnia

研究疾病代码:

Target disease code:

研究类型:

干预性研究

Study type:

Interventional study

研究所处阶段:

探索性研究/预试验 

Study phase:

0

研究设计:

随机平行对照 

Study design:

Parallel 

研究目的:

1) 开展随机对照试验,初步探索失眠障碍认知行为治疗不同技术成分的效果差异; 2) 从患者、治疗师的视角探究失眠认知行为治疗产生疗效的相关影响因素。  

Objectives of Study:

1) Carry out a randomized controlled trial to initially explore the effect of different technical components of cognitive behavioral therapy for insomnia disorders; 2) Explore the relevant factors affecting the efficacy of cognitive behavioral therapy for insomnia from the perspective of patients and therapists.

药物成份或治疗方案详述:

 

Description for medicine or protocol of treatment in detail:

 

纳入标准:

Inclusion criteria

排除标准:

1. 合并严重躯体疾病或精神疾病者;
2. 睡眠节律异常或其他的睡眠障碍类型者;
3. 物质滥用或镇静催眠药物依赖者;
4. 妊娠期和哺乳期妇女;
5. 轮休工作。

Exclusion criteria:

1. People with severe physical or mental illness;
2. People with abnormal sleep rhythm or other types of sleep disorders;
3. Substance abuse or sedative hypnotic drug dependence;
4. Pregnant and lactating women;
5. Shift work.

研究实施时间:

Study execute time:

From 2020-09-01 00:00:00 To 2021-12-31 00:00:00  

征募观察对象时间:

Recruiting time:

From 2020-09-01 00:00:00 To 2021-09-01 00:00:00

干预措施:

Interventions:

组别:

1

样本量:

30

Group:

1

Sample size:

干预措施:

认知行为治疗

干预措施代码:

Intervention:

Cognitive Behavior Therapy

Intervention code:

组别:

2

样本量:

30

Group:

2

Sample size:

干预措施:

认知治疗

干预措施代码:

Intervention:

Cognitive Therapy

Intervention code:

组别:

3

样本量:

30

Group:

3

Sample size:

干预措施:

行为治疗

干预措施代码:

Intervention:

Behavior Therapy

Intervention code:

组别:

4

样本量:

30

Group:

4

Sample size:

干预措施:

常规治疗组

干预措施代码:

Intervention:

treatment as usual

Intervention code:

研究实施地点:

Countries of recruitment and research settings:

国家:

中国

省(直辖市):

北京 

市(区县):

 

Country:

China

Province:

Beijing

City:

单位(医院):

首都医科大学附属北京安定医院 

单位级别:

三甲 

Institution
hospital:

Beijing Anding Hospital affiliated to Capital Medical University

Level of the institution:

Tertiary A

测量指标:

Outcomes:

指标中文名:

睡眠日记

指标类型:

主要指标

Outcome:

Sleep diary

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

匹兹堡睡眠质量指数

指标类型:

主要指标

Outcome:

Pittsburgh sleep quality index, PSQI

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

失眠严重程度指标

指标类型:

主要指标

Outcome:

Insomnia Severity Index, ISI

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

睡眠功能失调信念和态度量表

指标类型:

次要指标

Outcome:

Dysfunctional Beliefs and Attitudes about Sleep

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

贝克焦虑量表

指标类型:

次要指标

Outcome:

Beck Anxiety Inventory, BAI

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

多维疲劳量表

指标类型:

次要指标

Outcome:

Multidimensional Fatigue Inventory- 20, MFI- 20

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

采集人体标本:

Collecting sample(s)
from participants:

征募研究对象情况:

Recruiting status:

正在进行

Recruiting

年龄范围:

Participant age:

最小 Min age 18 years
最大 Max age 60 years

性别:

男女均可

Gender:

Both

随机方法(请说明由何人用什么方法产生随机序列):

应用随机数字表法,由北京安定医院统计人员非课题组人员编制。

Randomization Procedure (please state who generates the random number sequence and by what method):

use the random number table method, was compiled by the statisticians of Beijing Anding Hospital.

是否公开试验完成后的统计结果:

Calculated Results after the Study Completed public access:

公开/Public

盲法:

对评估者设盲

Blinding:

Blind method for evaluators.

试验完成后的统计结果(上传文件):

Calculated Results after
the Study Completed(upload file):

是否共享原始数据:

IPD sharing

是Yes

共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址):

2022年课题结题文章发表后,通过邮箱联系课题负责人孟繁强,邮箱mfq_1019@126.com

The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url):

After year 2022,when the study is finished and its result is published, please contact the study leader Meng Fanqiang via email at mfq_1019@126.com

数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC:

采用纸质版CRF,统一采集数据。待试验完成后采用spss软件统一录入和分析数据。

Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture:

This trial wil use paper CRF to collect data, after we finished the trial, SPSS will be used to input and analyze the data.

数据与安全监察委员会:

Data and Safety Monitoring Committee:

有/Yes

注册人:

Name of Registration:

 2020-09-02 04:12:43